Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

NCT00246974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Gefitinib

Sponsor

AstraZeneca